Meta-analysis demonstrates significant pain and symptom relief in patients with acute migraine, indicating its therapeutic efficacy.
This meta-analysis confirms the effectiveness of Zavegepant nasal spray in treating acute migraine, with significant improvements in pain and symptom relief. Further research is needed to determine the effect on pain relapse and overall safety.
No takes yet. Share an insight, caveat, or question.
Waqas et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: